Dr. Fuhr Presents on the Economics of Biosimilars

Econsult Solutions Senior Advisor, Dr. Joseph P. Fuhr, Jr, spoke at the conference, Biosimilars and Follow – On Biologics 2014 Americas, Clinical, Commercial, Regulatory, Technical Challenges and Key Considerations Overcome.

Dr. Fuhr’s remarks, ‘Economics of biosimilars – Challenges in bringing the next generation of biosimilars to the market’, covered the balance between innovation and competition, lessons from the European experience, barriers to US market entry and entry points, marketing opportunities, the response from competitors, and forecasts of what is next in the biologics market.

Dr. Fuhr is a professor of Economics at Widener University and his primary research areas are regulation, antitrust, health economics, telecommunications, sports economics and econometrics.  He has published over thirty journal articles. 

Biosimilars Phila Feb program 10

Share This